By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
PHARMA JOBS POSTPHARMA JOBS POSTPHARMA JOBS POST
  • HOME
  • FRESHERS
  • LOCATIONS
  • ABOUT US
  • CONTACT
  • DISCLAIMER
Notification
PHARMA JOBS POSTPHARMA JOBS POST
  • HOME
  • FRESHERS
  • LOCATIONS
  • ABOUT US
  • CONTACT
  • DISCLAIMER
Have an existing account? Sign In
Follow US
PHARMA JOBS POST © 2024 All Rights Reserved.
WhatsApp Group Join Now
Telegram Group Join Now
- Advertisement -
Ad imageAd image
Ad imageAd image
PHARMA JOBS POST > FDA approval > FDA Approves Novel Treatment for Hemophilia A or B, with or without Factor Inhibitors
FDA approvaltreatment

FDA Approves Novel Treatment for Hemophilia A or B, with or without Factor Inhibitors

RAJLAXMI
Last updated: April 16, 2025 1:50 pm
RAJLAXMI 2 months ago 62 Views
Share
SHARE

The U.S. Food and Drug Administration approved Qfitlia (fitusiran) for routine prophylaxis to prevent or reduce the frequency of bleeding episodes in adult and pediatric patients 12 years of age and older with hemophilia A or hemophilia B, with or without factor VIII or IX inhibitors (neutralizing antibodies).

“Today’s approval of Qfitlia is significant for patients with hemophilia because it can be administered less frequently than other existing options,” said Tanya Wroblewski, M.D., deputy director of the Division of Non-Malignant Hematology in the FDA’s Center for Drug Evaluation and Research. “This new treatment option highlights our continued efforts to improve the lives of patients with hemophilia.”

Hemophilia A and hemophilia B are genetic bleeding disorders caused by a dysfunction or deficiency of coagulation factor VIII (FVIII) or IX (FIX), respectively. Patients with these hemophilias are unable to clot properly and may bleed for a longer time than normal after injury or surgery. They may also have spontaneous bleeding in muscles, joints and organs, which can be life-threatening. These bleeding episodes are typically managed by either on-demand, episodic treatment or prophylaxis using products containing FVIII or FIX, or a product that mimics a factor.

Qfitlia does not replace the missing clotting factor. Rather, it reduces the amount of a protein called antithrombin, leading to an increase in thrombin, an enzyme critical for blood clotting.

Qfitlia is administered under the skin (subcutaneously) starting once every two months. The dose and frequency of injections are adjusted using the FDA-cleared INNOVANCE Antithrombin companion diagnostic test. This companion diagnostic is intended to monitor and—by informing dosing and frequency of injections—achieve antithrombin activity in the target range to reduce the risk of bleeding and to reduce the risk of excessive blood clotting. The FDA granted clearance of the INNOVANCE Antithrombin test to Siemens Healthcare Diagnostics GmbH.

Qfitlia’s efficacy and safety were assessed in two multicenter, randomized clinical trials which enrolled a total of 177 adult and pediatric male patients with either hemophilia A or hemophilia B. In one study, participants had inhibitory antibodies to FVIII or FIX and previously received on-demand treatment with medicines known as “bypassing agents” for bleeding. In the second study, participants did not have inhibitory antibodies to FVIII or FIX and previously received on-demand treatment with clotting factor concentrates. In the two randomized trials, participants received either a fixed dose of Qfitlia monthly or their usual on-demand treatment (bypassing agents or clotting factor concentrates) as needed for nine months. The fixed dose of Qfitlia is not approved because it led to excessive clotting in some patients.

Participants subsequently entered a long-term extension study in which they received an adjustable dose of Qfitlia based on periodic measurements of antithrombin activity. This antithrombin-based dosing regimen is the approved dosage regimen. Efficacy of Qfitlia using the antithrombin-based dosing regimen was established by comparing patients on this dosing regimen of Qfitlia during the long-term extension study to the on-demand control data from the two randomized clinical trials.

WhatsApp Group Join Now
Telegram Group Join Now
- Advertisement -
DEFINE ACADEMY DRUG REGULATORY AFFAIRSDEFINE ACADEMY DRUG REGULATORY AFFAIRS
TAGGED: FDA, Hemophilia A and B
Share This Article
Facebook Twitter LinkedIn Email Print
Previous Article Asipro Hiring for Production Roles – Walk-in Interview on 19 April
Next Article Axis Clinicals Hiring Bioanalytical Professionals | Walk-In Interview 25th April

RECENT POSTS

  • FDA Launches Agency-Wide AI Tool to Optimize Performance for the American People
  • MSN Labs Hiring for FAR&D | Walk-In Interview on 27th June 2025
  • Walk-In Interview at Ipca Labs, Silvassa – Hiring for Production, QA, QC, Engineering & More (29th June 2025)
  • Research Associate (Analytical Research) Job at Wockhardt – Apply Now!
  • Join HOF Pharma as a Documentation Specialist – Career Opportunity
  • Sekhmet Walk-In Interview for Freshers | Multiple Openings | 23–28 June
  • Axis Clinicals Hiring Freshers | Walk-In Drive for QA, QC, Medical Writing – 27 June
  • Join Honour Lab’s Walk-In Drive for QC/QA Positions – June 22, 2025
  • Piramal Pharma Hiring: Walk-In Interview for Production /Packing Executives – June 22, 2025
  • Walk-In Interview: Deputy Manager – Drug Quality Assurance (DQA) at Aurigene Oncology | 22 June 2025, Bangalore
  • Plant Head Opportunity in Pharma Manufacturing – OSD Expertise | BioPlus Life Science
  • PI Industries Walk-In Interview for Research Scientist on 29 June 2025 – Apply Now
  • Syngene Hiring for Discovery Chemistry | Walk-In Drive on 28th June 2025
JOIN WHATSAPP CHANNEL

Recent Jobs

  • Eris Lifesciences Limited

    Career Opportunities at Eris Lifesciences – Multiple Openings in QC, Warehouse & Soft Gel

    • North Guwahati, Assam
    • Eris Lifesciences Limited
  • Cadila Pharmaceuticals Limited

    Cadila Pharmaceuticals is Looking for Biotech QC Talent – 0 to 3 Years Experience

    • Dholka, Ahmedabad
    • Cadila Pharmaceuticals Limited
  • Panacea Biotec

    Panacea Biotec Walk-In Interview on June 21, 2025 – Multiple Openings in Vaccine & Oncology Plants

    • Sandholi, Baddi
    • Panacea Biotec
  • Glenmark Pharmaceuticals Ltd.

    Walk-In Alert: Glenmark Pharmaceuticals to Hire Pharma Professionals on 22nd June 2025

    • Baddi , Himachal Pradesh
    • Glenmark Pharmaceuticals Ltd.
  • Syneos Health®

    Apply Today! Syneos Health is Looking for Clinical Operations Professionals

    • Pune, India
    • Syneos Health®
  • Novartis

    Novartis is Hiring Interns in India – Jumpstart Your Career in Pharma!

    • Hyderabad (Office)
    • Novartis
  • IQVIA

    IQVIA Hiring Safety Associate Trainee – Freshers Welcome! | Kolkata Location

    • Kolkata, India
    • IQVIA
  • Aurore Life Sciences Pvt. Ltd.

    Aurore Life Sciences Hiring: Walk-In Interviews for R&D Trainee/Chemist Roles

    • Jeedimetla, Hyderabad, Telangana
    • Aurore Life Sciences Pvt. Ltd.
  • Gland Pharma Limited

    Gland Pharma Ltd. Walk-In Interview for Freshers & Experienced in Production (Sterile Injectables) – June 20, 2025

    • Pashamylaram, Telangana
    • Gland Pharma Limited
  • Ipca Laboratories Limited

    Ipca Laboratories Walk-In Interview for Freshers – Apprentice Roles for M.Sc. Microbiology/Biotechnology

    • Pithampur, Dist Dhar, Madhya Pradesh
    • Ipca Laboratories Limited
  • Emcure Pharmaceuticals Ltd

    Emcure Hiring for Multiple Departments at OSD Plant – Attend Walk-In on 21st June 2025

    • Surendranagar, Gujarat
    • Emcure Pharmaceuticals Ltd
  • Vee Healthtek Pvt Ltd

    Vee Healthtek Announces Walk-In Drive for Medical Coding Freshers in Trichy – June 21 & 22, 2025

    • Trichy
    • Vee Healthtek Pvt Ltd

Tags

Ahmedabad (65) ahmedabad pharma jobs (189) ahmedabad pharma vacancy (165) ahmedabad pharma walk in interview (89) Baddi Pharma Vacancy (59) Bangalore pharma company jobs (41) Bangalore pharma jobs (31) FRESHERS (181) freshers jobs in pharma industry (50) freshers pharmacy jobs (46) Hiring (119) Hiring jobs (484) Hyderabad (57) hyderabad pharma company jobs (184) hyderabad pharma jobs (94) hyderabad pharma jobs freshers (42) hyderabad pharma vacancies (111) hyd pharma jobs (31) indore pharma company vacancy (27) job alert (405) job Opportunity (246) Job search (483) job Vaccancy (467) Mumbai Pharma company jobs (34) Pharmacovigilance Jobs vacancy (38) Pharma jobs (104) Pharma jobs at Baddi (36) pharma jobs in hyderabad (84) pharma news (37) Pharma QA Jobs (35) pharma qa vacancy (28) pharma vacancy in ahmedabad (30) pharma walk in interview (44) Production (58) Production Department (73) QA (53) QC (77) QC Department (45) Quality Control (QC) (32) Regulatory Affairs (55) Regulatory Affairs Jobs Vacancy (63) Vadodara (33) Vadodara Pharma Job Vacancy (53) Walk In Drive (125) Walk In Interview (180)
PHARMA JOBS POSTPHARMA JOBS POST
Follow US
PHARMA JOBS POST © 2024 All Rights Reserved.
JOIN OUR WHATSAPP GROUP
JOIN OUR TELEGRAM GROUP
Welcome Back!

Sign in to your account

Lost your password?